182
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

High Level of Serum Uric Acid induced Monocyte Inflammation is Related to Coronary Calcium Deposition in the Middle-Aged and Elder Population of China: A five-year Prospective Cohort Study

, , , , , , , , , , & show all
Pages 1859-1872 | Published online: 12 Mar 2022

References

  • Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;131(1):7–13.
  • Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA. 2000;283(18):2404–2410.
  • Wu AH, Gladden JD, Ahmed M, Ahmed A, Filippatos G. Relation of serum uric acid to cardiovascular disease. Int J Cardiol. 2016;213:4–7.
  • Ruparelia N, Chai JT, Fisher EA, Choudhury RP. Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nat Rev Cardiol. 2017;14(5):314.
  • Kawamoto R, Tomita H, Oka Y, Ohtsuka N. Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Intern Med. 2006;45(9):605–614.
  • Rodrigues TC, Maahs DM, Johnson RJ, et al. Serum uric acid predicts progression of subclinical coronary atherosclerosis in individuals without renal disease. Diabetes Care. 2010;33(11):2471–2473.
  • Takayama S, Kawamoto R, Kusunoki T, Abe M, Onji M. Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome. Cardiovasc Diabetol. 2012;11:2.
  • Jayachandran M, Qu S. Harnessing hyperuricemia to atherosclerosis and understanding its mechanistic dependence. Med Res Rev. 2021;41(1):616–629.
  • Kimura Y, Yanagida T, Onda A, Tsukui D, Hosoyamada M, Kono H. Soluble Uric Acid Promotes Atherosclerosis via AMPK (AMP-Activated Protein Kinase)-Mediated Inflammation. Arterioscler Thromb Vasc Biol. 2020;40(3):570–582.
  • Puddu P, Puddu GM, Cravero E, Vizioli L, Muscari A. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. J Cardiol. 2012;59(3):235–242.
  • Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem. 1991;266(13):8604–8608.
  • Rock KL, Kataoka H, Lai JJ. Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol. 2013;9(1):13–23.
  • Zimmer S, Grebe A, Latz E. Danger signaling in atherosclerosis. Circ Res. 2015;116(2):323–340.
  • Flores-Gomez D, Bekkering S, Netea MG, Riksen NP. Trained Immunity in Atherosclerotic Cardiovascular Disease. Arterioscler Thromb Vasc Biol. 2021;41(1):62–69.
  • Lee S, Bartlett B, Dwivedi G. Adaptive Immune Responses in Human Atherosclerosis. Int J Mol Sci. 2020;21:23.
  • Hou ZH, Lu B, Gao Y, et al. Prognostic value of coronary CT angiography and calcium score for major adverse cardiac events in outpatients. JACC Cardiovasc Imaging. 2012;5(10):990–999.
  • Chaikriangkrai K, Velankar P, Schutt R, et al. Additive prognostic value of coronary artery calcium score over coronary computed tomographic angiography stenosis assessment in symptomatic patients without known coronary artery disease. Am J Cardiol. 2015;115(6):738–744.
  • Dzaye O, Dudum R, Mirbolouk M, et al. Validation of the Coronary Artery Calcium Data and Reporting System (CAC-DRS): dual importance of CAC score and CAC distribution from the Coronary Artery Calcium (CAC) consortium. J Cardiovasc Comput Tomogr. 2020;14(1):12–17.
  • Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303(16):1610–1616.
  • Qazi AH, Zallaghi F, Torres-Acosta N, Thompson RC, O’Keefe JH. Computed Tomography for Coronary Artery Calcification Scoring: mammogram for the Heart. Prog Cardiovasc Dis. 2016;58(5):529–536.
  • Wexler L, Brundage B, Crouse J, et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group. Circulation. 1996;94(5):1175–1192.
  • Kamimura D, Cain-Shields LR, Clark D, et al. Physical Activity, Inflammation, Coronary Artery Calcification, and Incident Coronary Heart Disease in African Americans: insights From the Jackson Heart Study. Mayo Clin Proc. 2021;96(4):901–911.
  • Ong KL, McClelland RL, Allison MA, et al. Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors. Metabolism. 2021;116:154706.
  • Lee TS, Lu TM, Chen CH, Guo BC, Hsu CP. Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway. Redox Biol. 2021;46:102108.
  • Mannarino MR, Pirro M, Gigante B, et al. Association Between Uric Acid, Carotid Intima-Media Thickness, and Cardiovascular Events: prospective Results From the IMPROVE Study. J Am Heart Assoc. 2021;10(11):e020419.
  • Drivelegka P, Forsblad-d’Elia H, Angeras O, et al. Association between serum level of urate and subclinical atherosclerosis: results from the SCAPIS Pilot. Arthritis Res Ther. 2020;22(1):37.
  • Geng S, Chen K, Yuan R, et al. The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis. Nat Commun. 2016;7:13436.
  • Wesselink E, van Baar H, van Zutphen M, et al. Inflammation Is a Mediating Factor in the Association between Lifestyle and Fatigue in Colorectal Cancer Patients. Cancers. 2020;12:12.
  • Michiels C, Puigdevall L, Cochez P, et al. A Targetable, Noncanonical Signal Transducer and Activator of Transcription 3 Activation Induced by the Y-Less Region of IL-22 Receptor Orchestrates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice. J Invest Dermatol. 2021;2:987.
  • Tercan H, Riksen NP, Joosten LAB, Netea MG, Bekkering S. Trained Immunity: long-Term Adaptation in Innate Immune Responses. Arterioscler Thromb Vasc Biol. 2021;41(1):55–61.
  • Luis-Rodriguez D, Donate-Correa J, Martin-Nunez E, et al. Serum urate is related to subclinical inflammation in asymptomatic hyperuricaemia. Rheumatology. 2021;60(1):371–379.
  • Fragoulis GE, Soulaidopoulos S, Sfikakis PP, Dimitroulas T, DK G. Effect of Biologics on Cardiovascular Inflammation: mechanistic Insights and Risk Reduction. J Inflamm Res. 2021;14:1915–1931.
  • Braga TT, Davanso MR, Mendes D, et al. Sensing soluble uric acid by Naip1-Nlrp3 platform. Cell Death Dis. 2021;12(2):158.
  • Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349(25):2399–2406.
  • Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med. 2005;118(8):816–826.
  • Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464(7293):1357–1361.
  • Li-Yu J, Clayburne G, Sieck M, et al. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol. 2001;28(3):577–580.
  • Han M, Kim H, Kim HJ, et al. Serum uric acid is associated with coronary artery calcification in early chronic kidney disease: a cross-sectional study. BMC Nephrol. 2021;22(1):247.
  • Liang L, Hou X, Bainey KR, et al. The association between hyperuricemia and coronary artery calcification development: a systematic review and meta-analysis. Clin Cardiol. 2019;42(11):1079–1086.
  • Kiss LZ, Bagyura Z, Csobay-Novak C, et al. Serum Uric Acid Is Independently Associated with Coronary Calcification in an Asymptomatic Population. J Cardiovasc Transl Res. 2019;12(3):204–210.